Measurement of Bladder Function Change In Patients With SVMs Before and After Surgical Intervention

NCT03280186 | Unknown

• 1 other identifier: otw-20170908
• Study Type: interventional
• Target: 100
• Locations: 0 countries
• Sites: N/A

Brief Summary

The investigators goal is to create a better understanding of patient with SVMs reported outcomes for bladder management strategies before and after surgery.

Conditions

Spinal Vascular Disorder Nos; Neurogenic Bladder Dysfunction Nos

Keywords

Spinal Vascular Malformations; Bladder; Surgical intervention; Urodynamics

Outcome Measures

Primary Outcomes (1)

• bladder function change in urodynamics

  bladder function will be better in urodynamics after surgery.

  postoperative 3 months and 12 months

Study Arms (1)

Patients With SVMs

EXPERIMENTAL

Patients with SVMs will be included in the group and undergo surgery.

Procedure: surgery

Interventions

surgery PROCEDURE

The minimally invasive surgical treatment methods and new techniques will be adopted such as spinal superselective angiography, preoperative embolization, intraoperative electrophysiological monitoring, intraoperative angiography, etc.

Patients With SVMs

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• \- patient diagnosed with spinal vascular diseases including intradural arteriovenous malformation, intradural arteriovenous fistula, dural arteriovenous fistula, extradural arteriovenous malformation, paravertebral arteriovenous malformation, paravertebral arteriovenous fistula, cobbs' syndrome, other spinal arteriovenous metameric syndromes involve the spinal cord. patient not received surgical or interventional treatment before patient with normal cardiac, renal and hepatic function patient capable of understanding the content of the patient information / Informed Consent Form patient willing and able to participate in the registry

You may not qualify if:

• \- patient received surgical treatment or interventional treatment before patient is pregnant patient allergic to iodine patient unable to complete follow-up patient with cerebral lesions patient with other spinal lesions patient with cardiac, renal or hepatic dysfunction

Sponsors & Collaborators

• Xuanwu Hospital, Beijing: lead

MeSH Terms

Interventions

Surgical Procedures, Operative

Study Officials

• Tongwen Ou, M.D

  Xuanwu Hospital, Beijing

  STUDY DIRECTOR

Central Study Contacts

Zhenhua Shang, M.D

CONTACT

17801117318; shangzhenhua16@126.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director of Urology

Study Record Dates

• First Submitted: September 8, 2017
• First Posted: September 12, 2017
• Study Start: January 1, 2022
• Primary Completion: October 1, 2022
• Study Completion: December 1, 2022
• Last Updated: April 29, 2020

Record last verified: 2020-04

Data Sharing

• IPD Sharing: Will not share